Brain renin-angiotensin system modifies the blood pressure response to intracerebroventricular cadmium in rats

References

• Amundsen, E., Putter, J., Friberger, P., Knos, M., Larsbraten, M., Claeson, G. (1979). Methods for the determination of glandular kallikrein by means of a cromogenic tripeptide substrate. Adv Exp Med 102A:83–95.
   Google Scholar
• Averill, D. B., Diz, D. I. (2000). Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata. Brain Res Bull 51:119–128.
   PubMed Web of Science ®Google Scholar
• Buggy, J., Fisher, A. E., Hoffman, W. E., Johnson, A. L., Phillips, M. I. (1975). Ventricular obstruction: effect of drinking induced by intracranial injection of angiotensin. Science 190:72–74.
   PubMed Web of Science ®Google Scholar
• Bunnemann, B., Fuxe, K., Ganten, D. (1992). The brain renin-angiotensin system: localization and general significance. J Cardiovasc Pharmacol 19:S51–S62.
   Google Scholar
• Chen, L., Liu, L., Luo, Y., Huang, S. (2008). MAPK and mTOR pathways are involved in cadmium-induced neural apoptosis. J Neurochem 105:251–261.
   PubMed Web of Science ®Google Scholar
• de Gasparo, M., Siragy, H. M. (1999). The AT2 receptor: fact, fancy, and fantasy. Regul Pept 81:11–24.
   PubMed Web of Science ®Google Scholar
• Demontis, M. P., Varoni, M. V., Volpe, A. R., Emanueli, C., Madeddu, P. (1998). Role of nitric oxide synthase inhibition in the acute hypertensive response to intracerebroventricular cadmium. Br J Pharmacol 123:129–135.
   PubMed Web of Science ®Google Scholar
• Dzau, V. J. (1998). Cardiac renin-angiotensin: molecular and functional aspects. Am J Med 84:22–27.
   Google Scholar
• Dzau, V. J., Akishita, M., Yamada, H. (1998). Role of the AT2 receptor in vascular development and remodelling. In: Ulfendahl, H. R., Aurell, M. (Eds.), Renin angiotensin (pp 37–45). London: Portland Press.
   Google Scholar
• Filipic, M., Hei, T. K. (2004). Mutagenicity of cadmium in mammalian cells: implication of oxidative DNA damage. Mutat Res 546:81–91.
   PubMed Web of Science ®Google Scholar
• Gusev, K., Domenighetti, A. A., Delbridge, L. M., Pedrazzini, T., Niggli, E., Egger, M. (2009). Angiotensin II-mediated adaptive and maladaptive remodelling of cardiomyocyte excitation-contraction coupling. Circ Res 105:42–50.
   PubMed Web of Science ®Google Scholar
• Haberl, R. L. (1994). Role of angiotensin receptor subtypes in the response of rabbit brain arterioles to angiotensin. Stroke 35:1476–1480.
   Google Scholar
• Hogarty, D. C., Speakman, E. A., Puig, V., Phillips, M. I. (1992). The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking, and vasopressin responses to central angiotensin. Brain Res 586:289–294.
   PubMed Web of Science ®Google Scholar
• Johnson, A. K., Gross, P. M. (1993). Sensory circumventricular organs and brain homeostatic pathways. FASEB J 7:678–686.
   PubMed Web of Science ®Google Scholar
• Liu, X., Bellamy, C. O. C., Bailey, M. A., Mullins, L. J., Dunbar, D. R, Kenion, C. J., et al. (2009). Angiotensin-converting enzyme is a modifier of hypertensive and organ damage. J Biol Chem 284:15564–15572.
   PubMed Web of Science ®Google Scholar
• Madeddu, P., Demontis, M. P., Varoni, M. V., Fattaccio, M. C., Palmieri, A., Anania, V. (1993). Verapamil prevents the acute hypertensive response to intracerebroventricular cadmium in conscious normotensive rats. Am J Hypertens 6:193–197.
   PubMed Web of Science ®Google Scholar
• Madeddu, P., Varoni, M. V., Demontis, M. P., Pinna Parpaglia, P., Glorioso, N., Anania, V. (1996). Urinary kallikrein: a marker of blood pressure sensitivity to salt. Kidney Int 49:1422–1427.
   PubMed Web of Science ®Google Scholar
• Madeddu, P., Varoni, M. V., Demontis, M. P., Chao, J., Simson, J. A., Glorioso, N., et al. (1997a). Kallikrein-kinin system and blood pressure sensitivity to salt. Hypertension 29:471–477.
   PubMed Web of Science ®Google Scholar
• Madeddu, P., Varoni, M. V., Palomba, D., Emanueli, C., Demontis, M. P., Glorioso, N., et al. (1997b). Cardiovascular phenotype of a mouse strain with disruption of B2-receptor gene. Circulation 96:3570–3578.
   PubMed Web of Science ®Google Scholar
• Madeddu, P., Vio, C. P., Straino, S., Salis, M. B., Milia, A. F., Emanueli, C. (2001). Renal phenotype of low kallikrein rats. Kidney Int 59:2233–2242.
   PubMed Web of Science ®Google Scholar
• Majima, M., Mizogami, S., Kuribayashi, Y., Katori, M, Oh-ishi, S. (1994). Hypertension induced by a nonpressor dose of angiotensin II in kininogen-deficent rats. Hypertension 24:111–119.
   PubMed Web of Science ®Google Scholar
• Martynowicz, H., Skoczynska, A., Wojakowska, A., Turczyn, B. (2004). Serum vasoactive agents in rats poisoned with cadmium. Int J Occup Med Environ Health 17:479–485.
   PubMedGoogle Scholar
• Mercure, C., Prescott, G., Lacombe, M. J., Silversides, D. W., Reudelhuber, T. L. (2009). Chronic increases in circulating prorenin are not associated with renal or cardiac pathologies. Hypertension 53:1062–1069.
   PubMed Web of Science ®Google Scholar
• Mizuno, K., Nakamata, M., Higashimori, K. (1988). Local generation and release of angiotensin II in peripheral vascular tissue. Hypertension 11:23–29.
   Google Scholar
• Moretti, J. L., Burke, S. L., Evans, R. G., Lambert, G. W., Head, G. A. (2009). Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension. J Hypertens 27:1838–1848.
   PubMed Web of Science ®Google Scholar
• Mulrow, P. J. (1993). The adrenal cortical renin-angiotensin system. In:Robertson, J. I. S., Nicholls, M. G. (Eds.), The renin-angiotensin system, vol 1 (pp 44.1–44.9). London: Gower Medical Publishing.
   Google Scholar
• Muntzenmayer, D. H., Greenm A. S. (1996). Opposing action of angiotensin II on microvascular growth and blood pressure. Hypertension 27:760–765.
   PubMed Web of Science ®Google Scholar
• Oite, T., Yao, J. (2009). Disturbance of glomerular hemodynamics: a risk factor determining progression of glomerular diseases? J Nephrol 22:196–202.
   PubMed Web of Science ®Google Scholar
• Oner, G., Senturk, U. K., Izgut-Uysal, V. N. (1996). Role of cadmium-induced lipid peroxidation in the kidney response to atrial natriuretic hormone. Nephron 72:257–262.
   PubMedGoogle Scholar
• Pendergrass, K. D., Gwathmey, T. M., Michalek, R. D., Graison, J. M., Chappel, M. C. (2009). The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus. Biochem Biophys Res Commun 384:149–154.
   PubMed Web of Science ®Google Scholar
• Pierucci-Alves, F., Schultz, B. D. (2008). Bradykinin-stimulated cyclooxygenase activity stimulates vas deferens epithelial anion secretion in vitro in swine and humans. Biol Reprod 79:501–509.
   PubMed Web of Science ®Google Scholar
• Pravanec, M., Cren, V., Cunes, J., Scicli, A. G., Carretero, O. A., Simonet, L., et al. (1991). Cosegregation of blood pressure with a kallikrein gene family polymorphism. Hypertension 17:242–246.
   PubMed Web of Science ®Google Scholar
• Puri, V. N., Tandon, V. (1997). Effect of repeated administration of cadmium, captopril, and its combination on plasma renin activity in rats. Pharmacol Res 36:411–414.
   PubMed Web of Science ®Google Scholar
• Puri, V. N. (1999). Cadmium-induced hypertension. Clin Exp Hypertens 21(1–2):79–84.
   PubMed Web of Science ®Google Scholar
• Reid, J. A. (1977). Is there a brain renin-angiotensin system? Circ Res 41:147–153.
   PubMed Web of Science ®Google Scholar
• Saavedra, J. M., Chevillard, C. (1982). Angiotensin-converting enzyme is present in the subfornical organ and other circumventricular organs of the rats. Neurosci Lett 29:123–127.
   PubMed Web of Science ®Google Scholar
• Saavedra, J. M. (1992). Brain and pituitary angiotensin. Endocr Rev 13:329–380.
   PubMed Web of Science ®Google Scholar
• Schinke, M., Baltatu, O., Bohm, M., Peters, J., Rascher, W., Bricca, G., et al. (1999). Blood pressure reduction and diabetes insipidus in transgenic rats deficent in brain angiotensinogen. Proc Natl Acad Sci 96:3975–3980.
   PubMed Web of Science ®Google Scholar
• Soares de Moura R., Resende, A. C., Emiliano, A. F., Tano, T., Mendes-Ribeiro, A. C., Correia, M. L., et al. (2004). The role of bradykinin, AT2, and angiotensin 1–7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat. Br J Pharmacol 141:860–866.
   PubMed Web of Science ®Google Scholar
• Song, Q., Chao, J., Chao, L. (1996). High level of circulating human tissue kallikrein induces hypotension in a transgenic mouse model. Clin Exp Hypertens 18:975–993.
   PubMed Web of Science ®Google Scholar
• Sudano, I., Noll, G. (2009). Dual blockade versus single blockade of the renin-angiotensin system in the light of ONTARGET. J Hypertens 27:S11–S14.
   Web of Science ®Google Scholar
• Szczepanska-Sadowska, E., Paczwa, P., Lon, S., Ganten, D. (1998). Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats. J Hypertens 16:1505–1514.
   PubMed Web of Science ®Google Scholar
• Tamura, K., Umemura, S., Nyui, N., Yamakawa, T., Yamaguchi, S., Ishigami, T., et al. (1996). Tissue-specific regulation of angiotensinogen gene expression in spontaneously hypertensive rats. Hypertension 27:1216–1223.
   PubMed Web of Science ®Google Scholar
• Teruya, H., Muratani, H., Takishita, S., Sesoko, S., Matayoshi, R., Fukiyama, K. (1995). Brain angiotensin II contributes to the development of hypertension in Dahl-Iwai salt-sensitive rats. J Hypertens 13:883–890.
   PubMed Web of Science ®Google Scholar
• Toda, N., Ayaziki, K., Okamura, T. (1990). Modification by endogenous prostaglandins of angiotensin II-induced contraction in dogs and monkey cerebral and mesenteric arteries. J Pharmacol Exp Ther 252:374–379.
   PubMedGoogle Scholar
• Varoni, M. V., Palomba, D., Satta, M., Satta, A., Anania, V. (2003a). Different response of intracerebroventricular cadmium administration on blood pressure in normal and low urinary kallikrein rats. Pharmacol Res 47:157–162.
   PubMed Web of Science ®Google Scholar
• Varoni, M. V., Palomba, D., Satta, M., Anania, V. (2003b). Low urinary kallikrein rats: different sensitivity of verapamil on hypertensive response to central acute cadmium administration. Vet Human Toxicol 45:202–206.
   PubMedGoogle Scholar
• Veerasingham, S. J., Raizada, M. K. (2003). Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 139:191–202.
   Google Scholar
• Waalkes, M. P. (2003). Cadmium carcinogenesis. Mutat Res 533:107–120.
   PubMed Web of Science ®Google Scholar
• Wang, J., Xiong, W., Yang, Z., Davis, T., Dewey, M. J., Chao, J., et al. (1994). Human tissue kallikrein induces hypotension in transgenic mice. Hypertension 23:236–243.
   PubMed Web of Science ®Google Scholar
• Wirth, K. J., Linz, W., Wiemer, G., Scholkens, B. A. (1997). Kinins and cardioprotection. Pharmacol Res 35:527–530.
   PubMed Web of Science ®Google Scholar